The Regulatory Innovation Meeting for Support of Biopharmaceutical CDMOs, overseen by the MFDS(Ministry of Food and Drug Safety), was held at the LOTTE BIOLOGICS office in Songdo. 

Alongside LOTTE BIOLOGICS, key industry players such as Sartorius Korea Biotech, STgen Bio, and five other bio-enterprises participated in the discussions. 

This meeting sets the stage for South Korea to secure itself as a frontrunner in the global biopharmaceutical manufacturing arena.